Close

Rating History for Cara Therapeutics (CARA) by Piper Sandler

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/14/2023 David Amsellem Downgrade Neutral
(Overweight)
1.00
(12.00)
1.05
(0.95)
-9.52% Details